NCT04894227View on ClinicalTrials.gov

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

1,080

Participants

Timeline

Start Date

May 11, 2021

Primary Completion Date

May 11, 2021

Study Completion Date

November 30, 2021

Conditions
COVID-19
Interventions
BIOLOGICAL

Inactivated SARS-CoV-2 Vaccine (Vero cell）

600SU inactivated virus in 0.5 mL of aluminium hydroxide solution per injection

Trial Locations (1)

223300

Jingliang Wu, Huai'an

All Listed Sponsors
lead

Sinovac Research and Development Co., Ltd.

INDUSTRY